Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

May 2026; Volume 46,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abe, TETSUYA

    1. You have access
      Laparotomy After Total Pelvic Exenteration: Current Status and Techniques for Ileal Conduit Preservation
      KOJI KOMORI, TAKASHI KINOSHITA, AKIRA OUCHI, TAKAYOSHI KISHIDA, TAKUYA KITAHARA, HIRONOBU YASUOKA, SHUICHIRO ANDO, SEIJI ITO, KAZUNARI MISAWA, YUICHI ITO, JUNPEI YAMAGUCHI, EIJI HIGAKI, TOMONARI ASANO, MASATAKA OKUNO, TAKAHIRO HOSOI, KOSUKE INADA, KIYOSHI NARITA, HIDENORI OJIO, MASASHI NEGITA, KOTARO OZAKI and TETSUYA ABE
      Anticancer Research May 2026, 46 (5) 2735-2741; DOI: https://doi.org/10.21873/anticanres.18153
  2. Abe, YOSHIKI

    1. You have access
      Risk Factors for Niraparib-induced Severe Anemia in Japanese Patients With Ovarian Cancer: A Multicenter Study
      YUKI OZAWA, HIROMU TANIGAWA, TATSUHIRO FUJIMIYA, YOSHIKI ABE, JOH HIROHARA, MARII SUEHIRO, YUKI TANAKA, NAOKI SHIBATA, TAKASHI YOKOKAWA, JUNICHI KUSANO, TORU ARASE and TAKUMA KOINUMA
      Anticancer Research May 2026, 46 (5) 2887-2897; DOI: https://doi.org/10.21873/anticanres.18167
  3. Adachi, YUKARI

    1. Open Access
      Serum Extracellular Vesicles Double-positive for CD9 and CD147 or for CD9 and CD63 Decrease After Surgical Resection in Patients With Colorectal Cancer: Potential Biomarkers of Residual Tumor
      YUKARI ADACHI, TAKERU MATSUDA, SACHIKO INUBUSHI, KEISUKE YASUDA, RYOTA ITO, NAOTO SHIRAKAMI, TAKAAKI TACHIBANA, MASAKI IMAI, HIROKI KAGIYAMA, TAKAO TSUNEKI, MASAYUKI ANDO, MASAFUMI SAITO, YUTAKA SUGITA, TARO IKEDA, YASUFUMI KOTERAZAWA, TOMOAKI AOKI, HITOSHI HARADA, YASUNORI OTOWA, NAOKI URAKAWA, HIRONOBU GOTO, HIROSHI HASEGAWA, SHINGO KANAJI, KIMIHIRO YAMASHITA, ROBERT M. HOFFMAN and YOSHIHIRO KAKEJI
      Anticancer Research May 2026, 46 (5) 2345-2352; DOI: https://doi.org/10.21873/anticanres.18121
  4. Alsharif, KHALAF F

    1. You have access
      Apoptotic Induction by 1,5-Diaryl-1,4-pentadien-3-one Derivatives in the HL60 Cell Line: In Vitro and In Silico Expression
      ARSHEE REHMAN, ZIA UDIN, YASAR SHAH, ABDUR RAUF, KHALAF F ALSHARIF, KHALID J. ALZAHRANI, ABDUL SABOOR PIRZADA, MARIA DAGLIA, MICHAEL ASCHNER and HAROON KHAN
      Anticancer Research May 2026, 46 (5) 2361-2373; DOI: https://doi.org/10.21873/anticanres.18123
  5. Alzahrani, KHALID J.

    1. You have access
      Apoptotic Induction by 1,5-Diaryl-1,4-pentadien-3-one Derivatives in the HL60 Cell Line: In Vitro and In Silico Expression
      ARSHEE REHMAN, ZIA UDIN, YASAR SHAH, ABDUR RAUF, KHALAF F ALSHARIF, KHALID J. ALZAHRANI, ABDUL SABOOR PIRZADA, MARIA DAGLIA, MICHAEL ASCHNER and HAROON KHAN
      Anticancer Research May 2026, 46 (5) 2361-2373; DOI: https://doi.org/10.21873/anticanres.18123
  6. Amakawa, YOSHIHIRO

    1. You have access
      Timing and Risk Factors for Hyperglycemia Associated With Anamorelin Administration
      YOSHIHIRO AMAKAWA, KAZUO KOBAYASHI, YUMA NONOMIYA, HISANORI SHIMIZU, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, NAOKI SASAHIRA, MASATO OZAKA, TSUYOSHI TAKEDA, KENSEI YAMAGUCHI, DAISUKE TAKAHARI, MAKOTO NISHIO, RYO ARIYASU, TORU KITAZAWA and MASAKAZU YAMAGUCHI
      Anticancer Research May 2026, 46 (5) 2725-2733; DOI: https://doi.org/10.21873/anticanres.18152
  7. Amemiya, HIDETAKE

    1. You have access
      Postoperative Changes in Nutritional Status and their Impact on Post-recurrence Prognosis After Pancreatoduodenectomy in Patients With Biliary Tract Carcinoma: An Age-stratified Analysis
      WATARU IZUMO, RYO SAITO, HIDETAKE AMEMIYA, SUGURU MARUYAMA, KOICHI TAKIGUCHI, KATSUTOSHI SHODA, KENSUKE SHIRAISHI, SHINJI FURUYA, YOSHIHIKO KAWAGUCHI, HIROMICHI KAWAIDA and DAISUKE ICHIKAWA
      Anticancer Research May 2026, 46 (5) 2817-2828; DOI: https://doi.org/10.21873/anticanres.18161
  8. Ando, KIYOHIRO

    1. You have access
      Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
      KEITA GOTO, KIYOHIRO ANDO, NORIKO MOTOI, TOSHIHIKO IIZUKA, HIROTAKA FUCHIZAWA, YUKI NAKAMURA, YUTA SANO, SHOTARO MATSUOKA, HISANORI TAKENOBU, MASAYUKI HARUTA, RITSUKO ONUKI, YOH MATSUOKA, TAKEHIKO KAMIJO and YUKIO KAGEYAMA
      Anticancer Research May 2026, 46 (5) 2445-2453; DOI: https://doi.org/10.21873/anticanres.18129
  9. Ando, KOJI

    1. You have access
      Practical Implementation and Validation of Geriatric Assessment in Older Adults With Esophageal Cancer
      TETSURO KAWAZOE, TOMONORI NAKANOKO, TOMOYA HARIMA, KEITA NATSUGOE, YUKI SHIN, SHO NAMBARA, YASUO TSUDA, KOJI ANDO, EIJI OKI and TOMOHARU YOSHIZUMI
      Anticancer Research May 2026, 46 (5) 2771-2779; DOI: https://doi.org/10.21873/anticanres.18157
  10. Ando, MASAYUKI

    1. Open Access
      Serum Extracellular Vesicles Double-positive for CD9 and CD147 or for CD9 and CD63 Decrease After Surgical Resection in Patients With Colorectal Cancer: Potential Biomarkers of Residual Tumor
      YUKARI ADACHI, TAKERU MATSUDA, SACHIKO INUBUSHI, KEISUKE YASUDA, RYOTA ITO, NAOTO SHIRAKAMI, TAKAAKI TACHIBANA, MASAKI IMAI, HIROKI KAGIYAMA, TAKAO TSUNEKI, MASAYUKI ANDO, MASAFUMI SAITO, YUTAKA SUGITA, TARO IKEDA, YASUFUMI KOTERAZAWA, TOMOAKI AOKI, HITOSHI HARADA, YASUNORI OTOWA, NAOKI URAKAWA, HIRONOBU GOTO, HIROSHI HASEGAWA, SHINGO KANAJI, KIMIHIRO YAMASHITA, ROBERT M. HOFFMAN and YOSHIHIRO KAKEJI
      Anticancer Research May 2026, 46 (5) 2345-2352; DOI: https://doi.org/10.21873/anticanres.18121
« Previous (Pages : 1 2 3 4 5 6 ... 45) Next »
Back to top
Previous

In this issue

Anticancer Research: 46 (5)
Anticancer Research
Vol. 46, Issue 5
May 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)

Issue highlights

  • Musashi1 Enhances Cell Growth and Increases Chemoresistance in Neuroblastoma
  • Gossypol Inhibits GLI3-dependent SHH Signaling to Selectively Target SPOP-deficient Breast Cancer Cells
  • Serum Extracellular Vesicles Double-positive for CD9 and CD147 or for CD9 and CD63 Decrease After Surgical Resection in Patients With Colorectal Cancer: Potential Biomarkers of Residual Tumor
  • Real-world Delivery and Outcomes of Intravesical BCG for Non–muscle-invasive Bladder Cancer
  • PRDX4 Potentially Serves as an Independent Marker for Early Recurrence of Oral Squamous Cell Carcinoma
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire